ArticleAnnals of surgical treatment and research2018

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival.

Jinsoo Rhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.